<DOC>
	<DOCNO>NCT01810835</DOCNO>
	<brief_summary>The prevalence HBsAg carriage pregnant woman varies France , accord native country , high rate originate sub-Saharan Africa Asia ( 5 8 % Parisian area ) . The level HBV-DNA varies accord HBe status geographical origin , strongly predictive risk HBV mother-to-child transmission ( MTCT ) . It show rate vertical transmission ( Chinese study Yuan J et al ) 0 % newborns mother HBV-DNA &lt; 105 copies/mL 40 % newborns mother high viral load &gt; 108 copies/mL , despite HBIg vaccine birth . Thus , data need concern current practice prevention HBV MTCT France , result .</brief_summary>
	<brief_title>Prevention Hepatitis B Virus Mother-to-child Transmission Serovaccination .</brief_title>
	<detailed_description>This monocentre , observational study include pregnant woman HBV-DNA &gt; 105 IU/mL . HBV MTCT rate evaluate , accord level HBV-DNA woman last three month pregnancy childbirth ( 105 108 IU/mL , &gt; 108 IU/mL ) , accord clinical practice serovaccination participate center . The evaluation base rate HBsAg positivity infant 9 month , despite correct immunization birth . The rate detectable HBV-DNA also evaluate infant date .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>Pregnant woman HBs Ag + HBVDNA &gt; 105 IU/mL Women treat HBV hepatitis , ( AST/ALT &gt; 2 ULN without explanation , liver biopsy perform pregnancy show hepatitis require initiation treatment )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>HBV mother-to-child transmission</keyword>
	<keyword>woman HBV DNA &gt; 105 I.U./mL</keyword>
	<keyword>France</keyword>
</DOC>